Mesa Laboratories, Inc. (FRA:MLI)
114.00
+3.00 (2.70%)
At close: May 13, 2025, 10:00 PM CET
Revenue by Product
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 |
Sterilization and Disinfection Control | 75.12M |
Log In |
Log In |
Log In |
Log In |
Sterilization and Disinfection Control Growth | 16.27% |
Log In |
Log In |
Log In |
Log In |
Clinical Genomics | 52.59M |
Log In |
Log In |
Log In |
Log In |
Clinical Genomics Growth | -15.59% |
Log In |
Log In |
Log In |
Log In |
Calibration Solutions | 47.76M |
Log In |
Log In |
Log In |
Log In |
Calibration Solutions Growth | 6.60% |
Log In |
Log In |
Log In |
Log In |
Biopharmaceutical Development | 40.71M |
Log In |
Log In |
Log In |
Log In |
Biopharmaceutical Development Growth | -14.05% |
Log In |
Log In |
Log In |
Log In |
Instruments | - |
Log In |
Log In |
Log In |
Log In |
Instruments Growth | - |
Log In |
Log In |
Log In |
Log In |
Continuous Monitoring | - |
Log In |
Log In |
Log In |
Log In |
Continuous Monitoring Growth | - |
Log In |
Log In |
Log In |
Log In |
Corporate and Other | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is April - March.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | Mar '19 Mar 31, 2019 |
United States | 106.40M |
Log In |
Log In |
Log In |
Log In |
United States Growth | -9.28% |
Log In |
Log In |
Log In |
Log In |
China | 24.93M |
Log In |
Log In |
Log In |
Log In |
China Growth | -3.35% |
Log In |
Log In |
Log In |
Log In |
Other | 84.86M |
Log In |
Log In |
Log In |
Log In |
Other Growth | 11.65% |
Log In |
Log In |
Log In |
Log In |